ELL anticorps (C-Term) (PE)
-
- Antigène Voir toutes ELL Anticorps
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Épitope
- AA 523-553, C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ELL est conjugé à/à la PE
-
Application
- Western Blotting (WB), ELISA
- Réactivité croisée
- Humain, Souris
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
- Attributs du produit
- ELL, CT (ELL, C19orf17, RNA polymerase II elongation factor ELL, Eleven-nineteen lysine-rich leukemia protein) (PE)
- Purification
- Purified by Protein A affinity chromatography.
- Immunogène
- ELL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 523-553 amino acids from the C-terminal region of human ELL.
- Isotype
- IgG
- Top Product
- Discover our top product ELL Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2.
- Stock
- 4 °C
- Stockage commentaire
- 4°C ,Do Not Freeze
-
- Antigène
- ELL (Elongation Factor RNA Polymerase II (ELL))
- Autre désignation
- ELL (ELL Produits)
- Synonymes
- anticorps wu:fc60b11, anticorps zgc:63836, anticorps C19orf17, anticorps ELL1, anticorps MEN, anticorps PPP1R68, anticorps Ell1, anticorps Men, anticorps elongation factor for RNA polymerase II, anticorps elongation factor RNA polymerase II, anticorps ELL, anticorps ell, anticorps Ell
- NCBI Accession
- NP_006523
- UniProt
- P55199
-